Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Baseline demographical and clinical characteristics in patients with low-energy distal radius fracture and controls who visited the osteoporosis centre at both inclusion and at one year follow up.

From: No long-term impact of low-energy distal radius fracture on health-related quality of life and global quality of life: a case-control study

  Distal radius fracture Controls p*
  n = 160 n = 169  
Demographics    
Age (years; mean (SD)) 67 (9) 66 (9) 0.457
Females 144 (90) 151 (89) 0.846
BMI (kg/m2) 25.7 (4.3) 26.7 (4.3) 0.027
Menarche (years; mean (SD)) 13.9 (1.5) 13.6 (1.4) 0.066
Menopause (years; mean (SD)) 48.9 (4.5) 49.6 (4.1) 0.086
Education    0.011
< 10 years 56 (38) 70 (42)  
11–13 years 61 (42) 45 (27)  
> 13 years 30 (20) 53 (31)  
Co-habiting 84(53) 112 (67) 0.011
Regular exercise** 119 (74) 126 (74) 0.970
Current smoker 23 (14) 21 (12) 0.604
Clinical characteristics    
Current calcium and/or vitamin D treatment 39 (24) 41 (24) 0.981
Current ART 28 (18) 22 (13) 0.258
Previous fractures 83 (52) 77 (47) 0.319
≥ 1 fall in the previous year 68 (47) 48 (36) 0.054
Osteoporosis 52 (32) 30 (18) <0.001
Osteopenia 83 (52) 74 (44)  
Normal BMD 25 (16) 64 (38)  
Heart diseases 48 (30) 58 (34) 0.402
Pulmonary diseases 19 (12) 12 (7) 0.138
Neurological diseases 12 (8) 14 (8) 0.792
Endocrine disorders 14 (9) 20 (12) 0.358
Gastrointestinal disorders 8 (5) 21 (12) 0.018
Urogenital disorders 5 (3) 1 (1) 0.086
Inflammatory joint disorders and connective tissue disorders 36 (23) 45 (26) 0.385
Cancer 16 (10) 19 (11) 0.715
Mental disorders 7 (4) 11 (7) 0.395
Co-morbidities (range 0–6) 1.0 (1.0) 1.2 (1.1) 0.191
  1. Mean (SD) for continuous variables and numbers (%) for categorical variables.
  2. *Bold p-values indicate significant differences between the groups
  3. ** Exercise more than 30 minutes three times a week.
  4. BMI, body mass index; ART, antiresorptive treatment, a specific osteoporosis treatment comprising biphosphonates, or selective oestrogen-receptor modulators.